Schonfeld Strategic Advisors’s Tevogen Inc. Common Stock TVGN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-312	Closed	-$161K	–	2738
2022 Q4	$161K	Hold	312	–	–	﹤0.01%	2056
2022 Q3	$158K	Hold	312	–	–	﹤0.01%	2419
2022 Q2	$156K	Buy	312 +4	+1%	+$2K	﹤0.01%	1987
2022 Q1	$154K	Buy	+308	New	+$153K	﹤0.01%	2068

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schonfeld Strategic Advisors's TVGN Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 312 shares — an estimated $161K sold.

Schonfeld Strategic Advisors first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $161K in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Schonfeld Strategic Advisors reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 312 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $161K.
Schonfeld Strategic Advisors first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Schonfeld Strategic Advisors's Tevogen Inc. Common Stock position peaked at $161K in Q4 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.